Instadose Pharma India Private Limited
About Instadose Pharma India Private Limited
Data last updated:
Instadose Pharma India Private Limited is a foreign private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2021FTC378819.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Grant Ferdinand Sanders and Braj Nath Singh.
Its last annual general meeting (AGM) was held on 01 December 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at J – 51 Mustatil No.10 Killa No.8 Defence Enclave, Delhi, India – 110071.
Company details
Contact details
Instadose Pharma India Private Limited's registered office is in Delhi, Delhi.
- Registered AddressJ – 51 Mustatil No.10 Killa No.8 Defence Enclave, Delhi, India – 110071
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Instadose Pharma India Private Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2020-21 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2020-21 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Instadose Pharma India Private Limited, buy the company report.
Board of directors of Instadose Pharma India Private Limited
Instadose Pharma India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Grant Ferdinand Sanders | Director | 18 Mar 2021 | 5 Years 7 Months | Current |
| Braj Nath Singh | Director | 18 Mar 2021 | 5 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Instadose Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Instadose Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Instadose Pharma India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Instadose Pharma India Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Braj Nath Singh was appointed as Director on 18 Mar 2021.
Frequently asked questions
Instadose Pharma India is an active foreign private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 March 2021 (5+ years old) and is registered under CIN U85100DL2021FTC378819.
Instadose Pharma India has 2 current directors:
- Grant Ferdinand Sanders - Director
- Braj Nath Singh - Director
The latest financial statements of Instadose Pharma India on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 01 December 2021. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Instadose Pharma India is U85100DL2021FTC378819. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Instadose Pharma India was incorporated on 18 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Braj Nath Singh was appointed as Director on 18 Mar 2021. Grant Ferdinand Sanders was appointed as Director on 18 Mar 2021.
The registered office of Instadose Pharma India is at J – 51 Mustatil No.10 Killa No.8 Defence Enclave, Delhi, India – 110071.
Instadose Pharma India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Instadose Pharma India can be reached at its registered office: J – 51 Mustatil No.10 Killa No.8 Defence Enclave, Delhi, India – 110071.
Instadose Pharma India is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
